These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16985166)

  • 1. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
    Wan TC; Ge ZD; Tampo A; Mio Y; Bienengraeber MW; Tracey WR; Gross GJ; Kwok WM; Auchampach JA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):234-43. PubMed ID: 17906066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.
    Ge ZD; van der Hoeven D; Maas JE; Wan TC; Auchampach JA
    J Mol Cell Cardiol; 2010 Aug; 49(2):280-6. PubMed ID: 20132822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
    Tian Y; Marshall M; French BA; Linden J; Yang Z
    Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
    Auchampach JA; Rizvi A; Qiu Y; Tang XL; Maldonado C; Teschner S; Bolli R
    Circ Res; 1997 Jun; 80(6):800-9. PubMed ID: 9168782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
    Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA.
    Smith SR; Denhardt G; Terminelli C
    Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
    Hussain A; Gharanei AM; Nagra AS; Maddock HL
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
    Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
    J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart.
    Hochhauser E; Kaminski O; Shalom H; Leshem D; Shneyvays V; Shainberg A; Vidne BA
    Antioxid Redox Signal; 2004 Apr; 6(2):335-44. PubMed ID: 15025935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IB-MECA and cardioprotection.
    Xu Z; Jang Y; Mueller RA; Norfleet EA
    Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.
    Harrison GJ; Cerniway RJ; Peart J; Berr SS; Ashton K; Regan S; Paul Matherne G; Headrick JP
    Cardiovasc Res; 2002 Jan; 53(1):147-55. PubMed ID: 11744023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
    Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
    J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA.
    Lasley RD; Narayan P; Jahania MS; Partin EL; Kraft KR; Mentzer RM
    Am J Physiol; 1999 Jun; 276(6):H2076-84. PubMed ID: 10362690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.
    Lee HT; Ota-Setlik A; Xu H; D'Agati VD; Jacobson MA; Emala CW
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F267-73. PubMed ID: 12388399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
    Takano H; Bolli R; Black RG; Kodani E; Tang XL; Yang Z; Bhattacharya S; Auchampach JA
    Circ Res; 2001 Mar; 88(5):520-8. PubMed ID: 11249876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.
    Tracey WR; Magee W; Masamune H; Oleynek JJ; Hill RJ
    Cardiovasc Res; 1998 Oct; 40(1):138-45. PubMed ID: 9876326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.